WHO ICTRP trial
Exploring the mechanism of phlegm-removing and blood-activating therapy in…
ITMCTR2025000550 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Not Recruiting
Key facts
| Trial ID | ITMCTR2025000550 |
|---|---|
| Public title | Exploring the mechanism of phlegm-removing and blood-activating therapy in obesity type 2 diabetes using multi-omics technology and assessing its clinical efficacy |
| Scientific title | Exploring the mechanism of phlegm-removing and blood-activating therapy in obesity type 2 diabetes using multi-omics technology and assessing its clinical efficacy |
| Primary sponsor | Shenzhen Traditional Chinese Medicine Hospital Shenzhen China |
| Registry | International Traditional Medicine Clinical Trial Registry (ITMCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Pilot clinical trial |
| Countries | China |
| Conditions | Type 2 Diabetes Mellitus with Obesity |
| Interventions | control group:Conventional Western medical treatment for diabetes along with lifestyle interventions and a placebo of Keluotong formula granules with a single dose of 10g three times daily orally before or after meals for a duration of 12… |
| Registration date | Mar 18, 2025 |
| Target size | control group:29;intervention group:29 |
| Registry page | itmctr.ccebtcm.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: